Reovirus type 2-infection, cycloheximide, and cell death.
D000935:Antifungal Agents / Q000494:pharmacology*; D046508:Culture Techniques; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D006367:HeLa Cells; D007930:Leucine / Q000378:metabolism; D012367:RNA, Viral / Q000096:biosynthesis*; D012087:Reoviridae / Q000187:drug effects*; D014316:Tritium; D014466:Ultraviolet Rays; D014764:Viral Proteins / Q000096:biosynthesis
D000935:Antifungal Agents; D012367:RNA, Viral; D014764:Viral Proteins; D014316:Tritium; D003609:Dactinomycin; D003513:Cycloheximide; D007930:Leucine